Hedge Funds Shift To Defensive Stocks As AI Doubts Grow

Hedge funds are cutting technology exposure as concerns about AI valuations grow, helping consumer staples and healthcare stocks outperform in October.

Hedge funds are reducing their exposure to technology stocks and increasing allocations to defensive equities as concerns about artificial intelligence valuations weigh on markets.

The MSCI global consumer staples index rose 10.6% in October, its strongest monthly gain since 1998. The MSCI global healthcare index gained 9.8%, its second-largest monthly advance of the century. By comparison, the MSCI global technology index has fallen more than 13% since the start of October.

The technology sell-off has affected funds with concentrated holdings in AI-related companies. Businesses with steadier earnings and cash flow have attracted greater interest as fund managers reassess sector allocations and protection against further declines.

Guy Miller, chief market strategist at Zurich, noted that technology stocks had become less attractive as investors sought greater diversification. Concerns have focused on whether the capital being invested in AI infrastructure will produce the earnings growth expected by investors.

Several defensive companies have gained since the Nasdaq 100 reached a peak on Oct. 6. Walmart shares have risen 15% since then, while Procter & Gamble and Coca-Cola have each gained about 10%.

Citigroup downgraded its recommendations on U.S. and global technology equities from overweight to neutral. Its strategists cited wider credit spreads, weaker earnings revisions and declining investor sentiment toward AI. They expect defensive stocks to continue outperforming more cyclical sectors into next year.

European equities have also benefited from the rotation. The region generally has less exposure to technology companies than the U.S. The Stoxx Europe 600 gained 1.5% in November, while the Nasdaq 100 fell more than 2%.

Articles by this author